Announcements Trials
Browse Landscape

Status

Completed 20Unknown 6Recruiting 6Active not recruiting 6Terminated 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 46Triple Negative Breast Neoplasms 10Colorectal Neoplasms 6Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Lung Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vulvar Neoplasms 1Vaginitis 1Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Osteosarcoma 1Multiple Myeloma 1Margins of Excision 1Lymphedema 1Liver Neoplasms 1Hypertension 1

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Uterine Neoplasms × Breast × Clear all
NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Wake Forest University Health Sciences

Suspended
22 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡